The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants
Open accessAbstract
BACKGROUND: Respiratory syncytial virus (RSV) is the dominant cause of severe lower respiratory tract infection in infants, with the most severe cases concentrated among younger infants. METHODS: Healthy pregnant women, at 28 weeks 0 days through 36 weeks 0 days of gestation, with an expected delivery date near the start of the RSV season, were randomly assigned in an overall ratio of approximately 2:1 to receive a single intramuscular dose of RSV fusion (F) protein nanoparticle vaccine or placebo. Infants were followed for 180 days to assess outcomes related to lower respiratory tract infection and for 364 days to assess safety. The primary end point was RSV-associated, medically significant lower respiratory tract infection up to 90 days of life, and the primary analysis of vaccine efficacy against the primary end point was performed in the per-protocol population of infants (prespecified criterion for success, lower bound of the 97.52% confidence interval [CI] of ≥30%). RESULTS: A total of 4636 women underwent randomization, and there were 4579 live births. During the first 90 days of life, the percentage of infants with RSV-associated, medically significant lower respiratory tract infection was 1.5% in the vaccine group and 2.4% in the placebo group (vaccine efficacy, 39.4%; 97.52% CI, -1.0 to 63.7; 95% CI, 5.3 to 61.2). The corresponding percentages for RSV-associated lower respiratory tract infection with severe hypoxemia were 0.5% and 1.0% (vaccine efficacy, 48.3%; 95% CI, -8.2 to 75.3), and the percentages for hospitalization for RSV-associated lower respiratory tract infection were 2.1% and 3.7% (vaccine efficacy, 44.4%; 95% CI, 19.6 to 61.5). Local injection-site reactions among the women were more common with vaccine than with placebo (40.7% vs. 9.9%), but the percentages of participants who had other adverse events were similar in the two groups. CONCLUSIONS: RSV F protein nanoparticle vaccination in pregnant women did not meet the prespecified success criterion for efficacy against RSV-associated, medically significant lower respiratory tract infection in infants up to 90 days of life. The suggestion of a possible benefit with respect to other end-point events involving RSV-associated respiratory disease in infants warrants further study. (Funded by Novavax and the Bill and Melinda Gates Foundation; ClinicalTrials.gov NCT02624947.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Modified Poisson Regression Approach to Prospective Studies with Binary Data
Zou, G. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh090 · Cited by 9,615
Shi, T., McAllister, D. A., O'Brien, K. L., Simoes, E. A. F., Madhi, S. A., Gessner, B. D., Polack, F. P., Balsells, E., Acacio, S., Aguayo, C., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30938-8 · Cited by 2,371
Self-citationVaccines against influenza WHO position paper – November 2012.
(2012) · PubMed · Cited by 1,122
Pertussis vaccines: WHO position paper - September 2015.
(2015) · PubMed · Cited by 295
Tetanus vaccines: WHO position paper – February 2017.
(2017) · PubMed · Cited by 268
O'Brien, K. L., Chandran, A., Weatherholtz, R., Jafri, H. S., Griffin, M. P., Bellamy, T., Millar, E. V., Jensen, K. M., Harris, B. S., Reid, R., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00247-9 · Cited by 190
August, A., Glenn, G. M., Kpamegan, E. P., Hickman, S. P., Jani, D., Lu, H., Thomas, D. N., Wen, J., Piedra, P. A., & Fries, L. F. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.05.045 · Cited by 99
Self-citationMuñoz, F. M., Swamy, G. K., Hickman, S. P., Agrawal, S., Piedra, P. A., Glenn, G. M., Patel, N., August, A., Cho, I., & Fries, L. F. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz390 · Cited by 98
Self-citationMuñoz, F. M., Eckert, L. O., Katz, M. A., Lambach, P., Ortiz, J. R., Bauwens, J., & Bonhoeffer, J. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.112 · Cited by 52
Morris, S. K., Dzolganovski, B., Beyene, J., & Sung, L. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-106 · Cited by 49
Cited by
A guide to vaccinology: from basic principles to new developments
Pollard, A. J., & Bijker, E. M. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00479-7 · Cited by 1,593
Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants
Hammitt, L. L., Dagan, R., Yuan, Y., Baca Cots, M., Bosheva, M., Madhi, S. A., Muller, W. J., Zar, H. J., Brooks, D., Grenham, A., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2110275 · Cited by 1,027
Self-citationRespiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape
Mazur, N. I., Terstappen, J., Baral, R., Bardají, A., Beutels, P., Buchholz, U. J., Cohen, C., Crowe, J. E., Cutland, C. L., Eckert, L., et al. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00291-2 · Cited by 420
Self-citationGebremedhin, A. T., Hogan, A. B., Blyth, C. C., Glass, K., & Moore, H. C. (2022) · Scientific Reports · doi:10.1038/s41598-021-04080-3 · Cited by 399
Lewnard, J. A., Charani, E., Gleason, A., Hsu, L. Y., Khan, W. A., Karkey, A., Chandler, C. I. R., Mashe, T., Khan, E. A., Bulabula, A. N. H., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00862-6 · Cited by 220
Metadata
- Authors
- Madhi, S. A., Polack, F. P., Piedra, P. A., Munoz, F. M., Trenholme, A. A., Simões, E. A. F., Swamy, G. K., Agrawal, S., Ahmed, K., August, A., Baqui, A. H., Calvert, A., Chen, J., Cho, I., Cotton, M. F., Cutland, C. L., Englund, J. A., Fix, A., Gonik, B., Hammitt, L., Heath, P. T., de Jesus, J. N., Jones, C. E., Khalil, A., Kimberlin, D. W., Libster, R., Llapur, C. J., Lucero, M., Pérez Marc, G., Marshall, H. S., Masenya, M. S., Martinón-Torres, F., Meece, J. K., Nolan, T. M., Osman, A., Perrett, K. P., Plested, J. S., Richmond, P. C., Snape, M. D., Shakib, J. H., Shinde, V., Stoney, T., Thomas, D. N., Tita, A. T., Varner, M. W., Vatish, M., Vrbicky, K., Wen, J., Zaman, K., Zar, H. J., Glenn, G. M., & Fries, L. F.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2020-07-30
- Volume
- 383
- Issue
- 5
- Pages
- 426-439
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3045880340
- Cited by
- 418
- References
- 10
- FWCI
- 40.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.